Dr Martin E Schlueter, MD | |
87 Conservatory Dr, Ste. A, Barberton, OH 44203-4291 | |
(330) 794-7993 | |
(330) 794-7996 |
Full Name | Dr Martin E Schlueter |
---|---|
Gender | Male |
Speciality | General Surgery |
Experience | 21 Years |
Location | 87 Conservatory Dr, Barberton, Ohio |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1972776862 | NPI | - | NPPES |
2877561 | Medicaid | OH | |
4249781 | Other | OH | MEDICARE ID |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208600000X | Surgery | 4301082420 (Michigan) | Secondary |
208600000X | Surgery | 35092131 (Ohio) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Summa Health System | Akron, OH | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Summa Physicians Inc | 2961303532 | 640 |
News Archive
Twenty years ago, few interventional cardiologists could have imagined that during their professional careers it would be possible to replace a diseased aortic valve using catheter-based techniques, rather than open-chest surgery.
Edison Pharmaceuticals announced today that the Committee for Orphan Medicinal Products (COMP), European Medicines Agency, has granted orphan designation to EPI-743 for the treatment of Leigh syndrome.
New York Gov. Eliot Spitzer (D) on Wednesday began airing a television advertisement defending a plan included in his fiscal year 2007-2008 budget proposal that would reduce state health care spending by about $1 billion, the New York Times reports (Hicks, New York Times, 3/1).
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Meclizine Hydrochloride Tablets USP, 12.5 mg, 25 mg and 50 mg.
› Verified 9 days ago
Entity Name | Summa Physicians Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1235167719 PECOS PAC ID: 2961303532 Enrollment ID: O20040116000295 |
News Archive
Twenty years ago, few interventional cardiologists could have imagined that during their professional careers it would be possible to replace a diseased aortic valve using catheter-based techniques, rather than open-chest surgery.
Edison Pharmaceuticals announced today that the Committee for Orphan Medicinal Products (COMP), European Medicines Agency, has granted orphan designation to EPI-743 for the treatment of Leigh syndrome.
New York Gov. Eliot Spitzer (D) on Wednesday began airing a television advertisement defending a plan included in his fiscal year 2007-2008 budget proposal that would reduce state health care spending by about $1 billion, the New York Times reports (Hicks, New York Times, 3/1).
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Meclizine Hydrochloride Tablets USP, 12.5 mg, 25 mg and 50 mg.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Martin E Schlueter, MD 87 Conservatory Dr, Ste. A, Barberton, OH 44203-4291 Ph: (330) 794-7993 | Dr Martin E Schlueter, MD 87 Conservatory Dr, Ste. A, Barberton, OH 44203-4291 Ph: (330) 794-7993 |
News Archive
Twenty years ago, few interventional cardiologists could have imagined that during their professional careers it would be possible to replace a diseased aortic valve using catheter-based techniques, rather than open-chest surgery.
Edison Pharmaceuticals announced today that the Committee for Orphan Medicinal Products (COMP), European Medicines Agency, has granted orphan designation to EPI-743 for the treatment of Leigh syndrome.
New York Gov. Eliot Spitzer (D) on Wednesday began airing a television advertisement defending a plan included in his fiscal year 2007-2008 budget proposal that would reduce state health care spending by about $1 billion, the New York Times reports (Hicks, New York Times, 3/1).
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Meclizine Hydrochloride Tablets USP, 12.5 mg, 25 mg and 50 mg.
› Verified 9 days ago
Dr. Mark W Byrge, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 210 5th St Ne, Ste. 8, Barberton, OH 44203 Phone: 330-475-1616 Fax: 330-475-1617 | |
Dr. Vincent Louis Sudimak, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 201 Fifth Street Ne Ste 2, Barberton, OH 44203 Phone: 330-475-1616 Fax: 330-475-1617 | |
Robert George Scarcella, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 101 5th St Se, Ste E, Barberton, OH 44203 Phone: 330-848-9209 Fax: 330-848-9210 | |
Dr. Craig Kornbau, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 201 5th St Ne Ste 10, Barberton, OH 44203 Phone: 330-753-1001 | |
Dr. Lee Anne Sprance, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 155 5th St Ne, Parkview Center, Barberton, OH 44203 Phone: 330-753-6717 Fax: 330-615-4161 |